| 000 | 01685 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513154111.0 | ||
| 264 | 0 | _c19981130 | |
| 008 | 199811s 0 0 eng d | ||
| 022 | _a0022-3042 | ||
| 024 | 7 |
_a10.1046/j.1471-4159.1998.71052112.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSpencer, J P | |
| 245 | 0 | 0 |
_aConjugates of catecholamines with cysteine and GSH in Parkinson's disease: possible mechanisms of formation involving reactive oxygen species. _h[electronic resource] |
| 260 |
_bJournal of neurochemistry _cNov 1998 |
||
| 300 |
_a2112-22 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_a3,4-Dihydroxyphenylacetic Acid _xmetabolism |
| 650 | 0 | 4 |
_a8,11,14-Eicosatrienoic Acid _xpharmacology |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aChromatography, High Pressure Liquid |
| 650 | 0 | 4 |
_aCopper _xpharmacology |
| 650 | 0 | 4 |
_aCysteine _xmetabolism |
| 650 | 0 | 4 |
_aDihydroxyphenylalanine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aDopamine _xmetabolism |
| 650 | 0 | 4 |
_aGlutathione _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoxanthine _xmetabolism |
| 650 | 0 | 4 |
_aIron _xpharmacology |
| 650 | 0 | 4 |
_aParkinson Disease _xmetabolism |
| 650 | 0 | 4 |
_aReactive Oxygen Species _xmetabolism |
| 650 | 0 | 4 | _aReference Values |
| 650 | 0 | 4 |
_aSuperoxides _xmetabolism |
| 650 | 0 | 4 |
_aXanthine _xmetabolism |
| 700 | 1 | _aJenner, P | |
| 700 | 1 | _aDaniel, S E | |
| 700 | 1 | _aLees, A J | |
| 700 | 1 | _aMarsden, D C | |
| 700 | 1 | _aHalliwell, B | |
| 773 | 0 |
_tJournal of neurochemistry _gvol. 71 _gno. 5 _gp. 2112-22 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1471-4159.1998.71052112.x _zAvailable from publisher's website |
| 999 |
_c9763353 _d9763353 |
||